The Multi-Modal Effect of the Anti-fibrotic Drug Pirfenidone on NSCLC.
Marwitz S, Turkowski K, Nitschkowski D, Weigert A, Brandenburg J, Reiling N, Thomas M, Reck M, Drömann D, Seeger W, Rabe KF, Savai R, Goldmann T.
Marwitz S, et al.
Front Oncol. 2020 Jan 21;9:1550. doi: 10.3389/fonc.2019.01550. eCollection 2019.
Front Oncol. 2020.
PMID: 32039023
Free PMC article.